D1 Receptor Agonist Ameliorates Synaptic and Behavioral Deficits in a Shank3-Deficient Mouse Model of Autism

References

[1] J. Peça, C. Feliciano, J. T. Ting, et al., “Shank3 Mutant Mice Display Autistic-Like Behaviours and Striatal Dysfunction,” Nature 472, no. 7344 (2011): 437-442.

[2] P. Kosillo and H. S. Bateup, “Dopaminergic Dysregulation in Syndromic Autism Spectrum Disorders: Insights from Genetic Mouse Models,” Front Neural Circuits 15 (2021): 700968.

[3] Y. Zhuang, B. Krumm, H. Zhang, et al., “Mechanism of Dopamine Binding and Allosteric Modulation of the Human D1 Dopamine Receptor,” Cell Research 31, no. 5 (2021): 593-596.

[4] S. Tzanoulinou, S. Musardo, A. Contestabile, et al., “Inhibition of Trpv4 Rescues Circuit and Social Deficits Unmasked by Acute Inflammatory Response in a Shank3 Mouse Model of Autism,” Molecular Psychiatry 27, no. 4 (2022): 2080-2094.

[5] A. L. Bey, X. Wang, H. Yan, et al., “Brain Region-Specific Disruption of Shank3 in Mice Reveals a Dissociation for Cortical and Striatal Circuits in Autism-Related Behaviors,” Translational Psychiatry 8, no. 1 (2018): 94.

RIGHTS & PERMISSIONS

2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.